Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |